UNIV - RHN Research Study Coordinator - Hollings Cancer Center

Medical University of South Carolina•Orangeburg, SC

1d•$45,300 - $77,000•Hybrid

About The Position

The Clinical Trials Office (CTO) is seeking a Research Study Coordinator. This position coordinates, establishes, and supervises complex research protocols at MUSC Orangeburg to efficiently and effectively integrate the National Cancer Institute (NCI), investigator-initiated, and industry-sponsored oncology trials at the Medical University of South Carolina (MUSC). This role actively promotes and increases awareness of the clinical trial program within MUSC’s community sites and exercises judgment regarding proper study participant management. This position will be split between Orangeburg and Charleston.

Requirements

A bachelor's degree
Two years of relevant program experience.

Responsibilities

Coordinates patient research related activities to accurately meet protocol requirements.
Ensure protocol compliance for study participants.
Ensures database updates to reflect accurate patient status.
Utilizes office tools including Sharepoint, Clinical Data Center (CDC), and clinical trial management system (CTMS).
Provides protocol specific information to physicians, primary nurses, and patients.
Coordinates the clinical work-up to determine patient eligibility.
Coordinates treatment plan and required follow-up with study participant, medical staff, nursing staff and ancillary hospital personnel.
Ensures that follow-up requirements per protocol are carried out in order to assess for response to treatment.
Works closely with clinical nurse staff to coordinate patient care to meet protocol standards.
Consults with the investigator to assess study participant for response to protocol therapy including toxicity assessment and disease status.
Coordinates and conducts activities associated with the preparation and shipment of protocol related samples within specified parameters.
Prepares, transports, and handles bloodborne pathogens and other human specimens following OSHA guidelines.
Enter and maintain both current and new study participant information into the clinical trials database.
New patient enrollments and status updates are to be entered into the CTMS within 24 hours of the enrollment or status change.
This includes Screening, Screen Failures, Consenting, Enrolling, Active on Treatment, Follow up, and Off study status.
New patient enrollments and status updates are to be entered/confirmed in EPIC within 24 hours of the enrollment and or status change.
This includes Consented- in screening, Enrolled-Receiving treatment and/or intervention, Enrolled-follow up only, lost to follow up, Screen failure and Completed.
Research participant protocol-related visits must be linked in EPIC prior to the encounter.
Assists investigators to identify, consent, screen, register/ enroll eligible patients to oncology studies at MUSC Orangeburg on behalf of Hollings Cancer Center.
Screens all patients at MUSC Orangeburg that are being screened for cancer, have been newly diagnosed, have progressed, or experienced a recurrence to potentially be included into a clinical trial.
Attends and actively participates in regularly scheduled multidisciplinary tumor boards, clinics, conferences, and any other forum where patients may be discussed.
Documents and tracks all screening efforts per departmental guidelines.
Establishes communication with physician investigators and care team regarding potential study participants.
Effective screening of HCC patient medical records requires knowledge of oncology terminology, medical terminology, disease specific staging and each clinical trial protocol eligibility criterion.
Meets regularly with their community site research team to discuss potential trial participants and plan for the upcoming week for all clinic coverage needs.
Under guidance of the team lead coordinator(s) and program manager, will support research activities at any of the MUSC main campus and HCC satellite locations and make necessary coverage plans in advance, to avoid interruption of quality CTO services.
Participates in and supports the informed consent process per departmental and institutional policy.
Timely and accurately collects and submits data to established research bases including the National Cancer Institute, industry sponsors, and MUSC.
Ensures data quality and timely completion and submission of case report forms (CRFs) and queries.
Develops and implements an effective daily routine which minimally includes retrieval of ongoing data from local or outside medical records, completion of appropriate case report forms and any data query received.
Ensures data is submitted according to sponsor mandated time frames and in a manner that affords maximum accuracy.
Ensures source documentation is present in-patient chart for case report form completion.
Visit-specific CRFs are to be completed per sponsor requirements.
Case report submission may include patient reported outcome questionnaires, radiologic scans, reports and staging tests.
Proactively plan, prioritize and manage responsibilities to ensure timely and accurate data submission to specified research bases.
Data submission is timely and accurate per the protocol, patient calendar, and source documents.
Collaborates with Data Coordinators as needed with patient protocol visits including adverse event logs, patient questionnaires, picking up specimens, and transporting study supplies.
Maintains established workflows to identify data needs of numerous trials within multiple disease groups and communicates data entry needs to study team.
Timely and accurately submits Adverse Events, Serious Adverse Events, and other reportable events to the NCI, sponsors, IRB and DSMC per federal guidelines and institutional policies.
Prepares and submits CTO-required and sponsor specific initial and follow up reports.
Adheres to the reporting requirements within the Clinical Trials Office, MUSC and various study sponsors.
Proactively plans to ensure reports are comprehensive and that reporting requirements are met within the allowable timeframe and in a manner that affords maximum accuracy.
Submits regulatory documents upon receipt to the Manager of Regulatory Compliance to ensure timely reporting by the regulatory unit of CTO.
This includes Adverse Event reports and protocol deviation reporting as well as any new protocol documents which may include but are not limited to protocol amendments, correspondence from sponsor, or any other documents requiring review and/or submission to IRB.
Additional non-regulatory reporting requirements would include submission of screening logs and database updates.
Protocol deviations will be reported to the clinical trials office regulatory unit per departmental processes.
Items that are outstanding per sponsor monitoring visit letters will be addressed and closed within 4 weeks of receiving the monitoring letter, or by the date of the monitor’s next site visit, whichever is earlier.
Maintain working knowledge of region-specific trial portfolio and participate in disease focus group meetings to support trial start up process for new studies and maintenance of protocol amendments.
Presents pertinent research related data to the research focus group and individual investigators.
Maintains up to date protocol information, communication and education of study and clinic personnel.
Assists in planning, implementing, and evaluation of program expansion and new projects.
Positively and professionally contributes to working groups and meetings.
Initiates and organizes meetings and prepares meeting agendas.
Discusses high priority trials.
Presents protocols to programs and clearly assesses patient population and feasibility of trial.
During the “In Approval Process-Step 1” reviews new protocols, completes the initial roadmap submission by designated timeline and obtains study specific credentialing per protocol requirements.
Collaborates with the CTO nurse managers in development of initial roadmap and amended roadmaps as applicable.
As protocol amendments are received amended roadmaps are completed by the assigned date to ensure patient safety.
Completes the Initial roadmap submission by assigned due date.
Roadmap submission forms are comprehensive and include all study assessments required per the protocol and study calendar.
Roadmap submission forms are accurate including treatment arms, hold and call parameters and dosing modifications per the protocol guidelines.